TD Cowen Maintains Repare Therapeutics(RPTX.US) With Buy Rating
TD Cowen Reaffirms Their Buy Rating on Repare Therapeutics (RPTX)
Piper Sandler Maintains Repare Therapeutics(RPTX.US) With Buy Rating, Maintains Target Price $25
Repare Therapeutics Analyst Ratings
Repare Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Immunovant (IMVT), Repare Therapeutics (RPTX)
Repare Therapeutics (RPTX) Gets a Buy From Piper Sandler
Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Repare Therapeutics (RPTX) and Penumbra (PEN)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Repare Therapeutics (RPTX) and Demant (OtherWILLF)
Buy Rating Reaffirmed for Repare Therapeutics on Strong Clinical Outlook and Attractive Valuation
Repare Therapeutics Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Repare Therapeutics, Maintains $10 Price Target
Buy Rating Affirmed for Repare Therapeutics: Strong Financials and Promising Clinical Catalysts Ahead
Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)
Repare Therapeutics Analyst Ratings
Repare Therapeutics Analyst Ratings
Piper Sandler Keeps Their Buy Rating on Repare Therapeutics (RPTX)
Buy Rating on Repare Therapeutics: Solid Financials and Promising Oncology Pipeline Despite Roche Setback
Analysts Offer Insights on Healthcare Companies: Pacira Pharmaceuticals (PCRX) and Repare Therapeutics (RPTX)
Piper Sandler Sticks to Their Buy Rating for Repare Therapeutics (RPTX)